Garey KW, Alwani A, Danziger LH, Rubinstein IR: Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest. 2003, 123: 261-265. 10.1378/chest.123.1.261
Article
PubMed
Google Scholar
Sugiyama Y, Yanagisawa K, Tominaga SI, Kitamura S: Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. Eur Respir J. 1999, 14: 1113-1116. 10.1183/09031936.99.14511139
Article
CAS
PubMed
Google Scholar
Kohyama T, Takizawa H, Kawasaki S, Akiyama N, Sato M, Ito K: Fourteen member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. Antimicrob Agents Chemother. 1999, 43: 907-911.
PubMed Central
CAS
PubMed
Google Scholar
Abe S, Nakamura H, Inoue S, Takeda H, Saito H, Kato S, Mukaida N, Matsushima K, Tomoike H: Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2000, 22: 51-60.
Article
CAS
PubMed
Google Scholar
Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, Ohtake H, Makino S: Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol. 1996, 98: S207-S215.
Article
CAS
PubMed
Google Scholar
Sato E, Nelson DK, Koyama S, Hoyt JC, Robbins RA: Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro. Antimicrob Agents Chemother. 2001, 45: 401-406.
Article
PubMed Central
CAS
PubMed
Google Scholar
Morikawa K, Watabe H, Arake M, Morikawa S: Modulatory effects of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother. 1996, 40: 1366-70.
PubMed Central
CAS
PubMed
Google Scholar
Kamoi H, Kurihara N, Fujiwara H, Hirata K, Takeda T: The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma. J Asthma. 1995, 32: 191-197.
Article
CAS
PubMed
Google Scholar
Cazzola M, Salzillo A, Diamare F: Potential role of macrolides in the treatment of asthma. Monaldi Arch Chest Dis. 2000, 55: 231-236.
CAS
PubMed
Google Scholar
Shimizu T, Shimizu S, Hattori R, Gabazza EC, Majima Y: In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells. Am J Respir Crit Care Med. 2003, 168: 581-587. 10.1164/rccm.200212-1437OC
Article
PubMed
Google Scholar
Shimane T, Asano K, Mizutani T, Suzaki H: Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro. In Vivo. 1999, 13: 503-506.
CAS
PubMed
Google Scholar
Chu HW, Kraft M, Rex M, Martin R: Evaluation of blood vessels and edema in the airways of asthma patients: Regulation with clarithromycin treatment. Chest. 2001, 120: 416-422. 10.1378/chest.120.2.416
Article
CAS
PubMed
Google Scholar
Terao H, Asano K, Kanai K, Kyo Y, Watanabe S, Hisamitsu T, Suzaki H: Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. Mediators Inflamm. 2003, 12: 195-202. 10.1080/09629350310001599620
Article
PubMed Central
CAS
PubMed
Google Scholar
Spector S, Katz F, Farr R: Troleandomycin: effectiveness in steroid dependent asthma and bronchitis. J Allergy Clin Immunol. 1974, 54: 367-379.
Article
Google Scholar
Weinberger M, Hudgel D, Spector S, Chisey C: Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol. 1977, 59: 228-231.
Article
CAS
PubMed
Google Scholar
Black PN: Anti-inflammatory effects of macrolide antibiotics. Eur Respir J. 1997, 10: 971-972. 10.1183/09031936.97.10050971
Article
CAS
PubMed
Google Scholar
Rosenberg SM, Gerhard H, Grunstein MM: Use of TAO without methylprednisolone in the treatment of severe asthma. Chest. 1991, 100: 849-850.
Article
CAS
PubMed
Google Scholar
Gotfried MH Jr, Messick C, Rubinstein IR: Placebo-controlled trial evaluating the efficacy of clarithromycin in subjects with corticosteroid dependent asthma. Birmingham, UK: 21st international Congress of chemotherapy. 1999.
Google Scholar
Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH: Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone dependent asthma. Chest. 2000, 118: 1826-1827. 10.1378/chest.118.6.1826
Article
CAS
PubMed
Google Scholar
Miyatake H, Taki F, Taniguchi H, Suzuki R, Takagi K, Satake T: Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest. 1991, 99: 670-673.
Article
CAS
PubMed
Google Scholar
Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Ishizaki Y: Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol. 2000, 84: 594-598.
Article
CAS
PubMed
Google Scholar
Ekici A, Ekici M, Erdemoglu AK: Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma. 2002, 39 (2): 181-185. 10.1081/JAS-120002199
Article
CAS
PubMed
Google Scholar
Tamaoki J, Tagaya E, Sakai A: Effects of macrolide antibiotics on neurally mediated contraction of human isolated bronchus. J Allergy Clin Immunol. 1995, 95: 853-859.
Article
CAS
PubMed
Google Scholar
Rubin BK, Druce H, Ramirez OE, Palmer R: Effect of clarithromycin on nasal mucus properties in healthy subjects and inpatients with purulent rhinitis. Am J Respir Crit Care Med. 1997, 155: 2018-2023.
Article
CAS
PubMed
Google Scholar
Hahn DL: Chlamydia pneumoniae and asthma. Thorax. 1998, 53: 1095-1096.
Article
CAS
PubMed
Google Scholar
Seggev JS, Lis I, Siman-Tov R, Gutman R, Abu-Samara H, Schey G, Naot Y: Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy. 1986, 57: 262-265.
Google Scholar
Hahn DL: Chlamydia pneumoniae, asthma, and COPD: what is the evidence? Ann Allergy Asthma Immunol. 1999, 83: 271-288.
Article
CAS
PubMed
Google Scholar
Dakhama A, Kraft M, Martin R, Gelfand EW: Induction of regulated upon activation, normal T-cells expressed and secreted (RANTES) and transforming growth factor-β1 in airway epithelial cells by Mycoplasma pneumoniae. Am J Respir Cell Mol Biol. 2003, 29: 344-351. 10.1165/rcmb.2002-0291OC
Article
CAS
PubMed
Google Scholar
Kraft M, Cassell G, Pak J: Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin. Chest. 2002, 121: 1782-1788. 10.1378/chest.121.6.1782
Article
CAS
PubMed
Google Scholar
Black PN, Blasi F, Jenkins CR: Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med. 2001, 164: 536-541.
Article
CAS
PubMed
Google Scholar